Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,860.00
+105.00 (2.21%)
At close: Jun 4, 2026
-3.76% (1Y)
| Market Cap | 52.28B -12.3% |
| Revenue (ttm) | 20.98B -6.2% |
| Net Income | 3.42B +45.4% |
| EPS | 301.97 +37.5% |
| Shares Out | 11.04M |
| PE Ratio | 15.68 |
| Forward PE | n/a |
| Dividend | 185.00 (3.91%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 22,688 |
| Open | 4,615.00 |
| Previous Close | 4,755.00 |
| Day's Range | 4,615.00 - 5,050.00 |
| 52-Week Range | 4,560.00 - 7,690.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 4, 2026 |